INTRODUCTION AND OBJECTIVES: Patients with diabetes mellitus (DM) have lower urine pH and a higher prevalence of uric acid calculi. It is unknown if glycemic control by patients with DM improves urinary risk factors for stones. We examined the association of hemoglobin A1c (HgbA1c), a measure of long-term DM control, with 24hr urine risk factors for uric acid and calcium calculi.
INTRODUCTION AND OBJECTIVES: Patients with diabetes mellitus (DM) have lower urine pH and a higher prevalence of uric acid calculi. It is unknown if glycemic control by patients with DM improves urinary risk factors for stones. We examined the association of hemoglobin A1c (HgbA1c), a measure of long-term DM control, with 24hr urine risk factors for uric acid and calcium calculi.
METHODS: With IRB approval, we identified 278 stone formers (SF) with 24h urine collections and HgbA1c measures obtained within 3 months of the urine collection. Relative saturation indices (RS) were calculated using EQUIL2. Patients were separated by glycemic status: normoglycemic (NG, HgbA1c<6.5) and hyperglycemic (HG, HgbA1c6.5); 24-h urine parameters were compared. The NG cohort was further divided into those with no history of DM and those with well controlled DM, characterized by HgbA1c<6.5 near the time of their 24-h urine collection. Variables were analyzed using chi squared, Welch 0 s t-test and multivariate linear regression to adjust for BMI, age, gender, and for thiazide and/or potassium citrate use.
RESULTS: Patients in the HG group were older (63 vs 60, p<0.01) and had higher BMI (35.1 vs 31.5, p<0.01). Multivariate analysis revealed that, overall, hyperglycemia was associated with lower pH (5.85 vs 6.30, p<0.001), higher uric acid RS (1.39 vs 0.69, p<0.001), and lower brushite RS (0.85 vs 1.60, p<0.001). SFs with history of DM who were well controlled had similar risk factors for uric acid stone to SFs with no history of DM (pH 6.2 vs 6.4, p¼0.50, and uric acid RS 0.87 vs 0.56, p¼0.85). Patients with a history of DM had a higher median urine calcium (223 mg/d vs 160, p¼0.05) and corresponding higher calcium oxalate RS (1.90 vs 1.46, p¼0.02) than SFs with normal HgbA1c.
CONCLUSIONS: Our study suggests that successful glycemic control may be associated with reduced urinary risk factors for uric acid stone formation. With good glycemic control, patients with DM had equivalent uric acid risk factors to those with no DM history and a subclinical increase in urinary risk factors for calcium stones. Our findings support promoting glycemic control as a component of the multidisciplinary medical management of stone disease. This provides us with the direction needed to reveal whether glycemic control reduces stone risk factors.
Source of Funding: None

MP90-02 ORAL DISSOLUTION THERAPY (ODT) FOR LUCENT RENAL CALCULI; CAN WE PREDICT THE OUTCOME?
Amr Elsawy*, Ahmed Elshal, Ahmed El-Nahas, Mohamed Elbaset, Hashim Farag, Ahmed Shokeir, Mansoura, Egypt INTRODUCTION AND OBJECTIVES: Oral dissolution therapy (ODT) for lucent renal calculi is non-invasive effective therapeutic approach however;responders to this approach are not well characterized.
METHODS: After obtaining IRB approval, patients with renal stones of less than 600 HU core attenuation value in non contrast computed tomography (NCCT) and without significant hydronephrosis were counseled for 3 months ODT. ODT entails oral potassium citrate 20 mEq three times daily, 3 liters of daily fluid intake and dietary regimen. Patients were followed up at 2,4,8 and12weeks,for assessment of ODT compliance and urine analysis. Patients with poor compliance (> one visit) were excluded from final analysis. Study's end point was change in stone surface area as measured by NCCT at3 months. At 3 months, ODT non-responders were scheduled for secondary intervention and ODT partial responders (reduced stone SA) were asked to choose between ODT extra 3 months vs.immediate secondary intervention. Predictors for 3months ODT-stone free rate and final ODT-success rate were assessed.
RESULTS: Between February 2015 and January 2016:out of 212 legible patients, 182 patients were compliant for ODT and were included in the final analysis. Figure1 summarizes, ODT responders at3 and 6 months. NCCT depicted 97(45.7%) and 57(31.3%)stone free responders at 3 and 6 months respectively. Table 1 , summarizes variables that predict less stone free probability 3 months following start of ODT. On multivariate analysis,only proteinuria at urine dipstick at enrollment(p¼0.003), stone density (p¼0.01) and uric acid level at 8 weeks after treatment (p¼0.03) independently predicts less stone free probability 3 months following start of ODT. Table 2 summarizes variables that predict ODT failure at6months. On multivariate analysis, only higher stone density (p¼0.03) and lower urine PH at 12 weeks after treatment (p¼0.01) independently predict ODT failure at 6 months. The cut-off point of stone density associated with less probability of e1210 THE JOURNAL OF UROLOGY â Vol. 197, No. 4S, Supplement, Tuesday, May 16, 2017 successful ODT for is 463.5HU (67.7% Sensitivity, 68.9% Specificity, AUC 0.7, P¼0.007). CONCLUSIONS: Regardless stone size, ODT is an effective treatment approach for renal stones. Key factors in determining potential ODT responders are treatment compliance achieving targeted urine PH and low stone density.
Source of Funding: none
MP90-03 INVESTIGATING SMART WATER BOTTLE TECHNOLOGY AS A CLINICAL TOOL FOR STONE FORMERS
INTRODUCTION AND OBJECTIVES: Improved methods of stone prevention are needed to combat rising rates of nephrolithiasis. Achieving adequate fluid intake is an effective strategy; yet, patient compliance with recommendations is generally poor. Mobile health applications and smart technology show promise as tools to improve compliance with medically indicated dietary treatments; however, have yet to be applied specifically towards stone formers with low urinary volume. Recently, a smart water bottle (HidrateSpark TM , Boulder, CO) was introduced as a noninvasive fluid intake monitoring system. This device could conceivably help patients who form stones from low urine volume achieve sustainable improvements in hydration, but has yet to be validated as a useful instrument. We sought to verify its accuracy prior to considering its potential as a medical aide.
METHODS: HidrateSpark (Figure 1 ) uses capacitive touch sensing via a sensor extending from the lid to base, which calculates volume measurements by detecting changes in water level. Data from the bottle is sent wirelessly to users 0 smartphones through an application. A pilot study was conducted to assess accuracy of measured fluid intake over 24 hour periods when used in a real life setting. Subjects were provided smart bottles to sync with their smartphone and given short tutorials on their use. Accuracy was determined by comparing 24 hour measurements recorded through the smart bottle to hand measurements from the corresponding 24 hour period. RESULTS: Eight subjects performed 62 24-hour measurements (range 4-14). Mean 24 hour hand measurement was 57.2 ozs (21-96). Corresponding mean 24 hour smart bottle measurement underestimated true fluid intake by a mean of 0.5 ozs (95% CI -1.9, 0.9). The percent difference between hand and smart bottle measurements was 0.0% (95% CI -3%, 3%). The intraclass correlation coefficient (ICC) was calculated to assess consistency between hand measures and bottle measures. The ICC (95% CI) was found to be 0.97 (0.95,0.98) indicating and extremely high consistency between measures.
CONCLUSIONS: 4 hour fluid intake measurements taken through a novel fluid monitoring system (HidrateSpark) are accurate to within 3%. Such technology may be useful as a behavioral aide and/or research tool particularly among recurrent stone formers with low urinary volume.
Source of Funding: None
MP90-04
A NOVEL USE OF STRUCTURED WATER FOR THE PREVENTION OF RECURRENT STONES IN IDIOPATHIC HYPERCALCIURIA.
Ali Sami*, Suleimany, Iraq INTRODUCTION AND OBJECTIVES: The majority of stones (85%) contain primarily calcium oxalate. Most renal stones are idiopathic calcium stones, and the most common predisposing factor in these patients is hypercalciuria. Structured water is a new type of water that has been prepared using different types of energy fields and modulators to produce this structured water that has new and different characteristics from the ordinary water. In this study, we compared the efficacy of the structured water (Magnalifeâ) with hydrochlorothiazide and with ordinary bottled water in the prevention of recurrent renal stones in patients with idiopathic hypercalciuria.
METHODS: We conducted a three-year randomized trial comparing the effect of structured water with the effect of hydrochlorothiazide and ordinary bottled water in 300 patients with recurrent calcium oxalate stones and hypercalciuria. 100 men used structured water (Magnalifeâ). The other 100 men used 50 mg hydrochlorothiazide, and 100 men used ordinary bottled water. Urine analysis with renal ultrasonography and radiology were done at baseline and at yearly intervals and any time of recurrence and at the end of the 3 years (36th month). All patients were informed and signed a written informed consent form.
RESULTS: Of the 300 men included in this study, 95 had recurrent stones, 15 men (15%) in the group of structured water ,31 men (31%) in the hydrochlorothiazide group, and 49 men (49%) in the group of ordinary bottled water. The difference in the recurrence rate between the structured water group and the hydrochlorothiazide group is significant (P¼0.007) Also the difference between the difference between the structured water group and the ordinary water group is significant (p<0.001), furthermore the hydrochlorothiazide group and the ordinary bottled water group recurrence rate is significantly different (P¼0.009).
CONCLUSIONS: Structured water is a safe, effective, and affordable new way to prevent recurrent urinary stones without the need for medications that are expensive and have many side effects. Furthermore, it is more potent than some preventive measures and drugs as a prophylactic way against recurrent urinary stones. It is far more effective than ordinary bottled water in preventing recurrent stones. Further studies are recommended to explore its role in other fields of urology.
